|
市場調査レポート
商品コード
1373880
CRISPR技術の世界市場 - 市場規模、シェア、成長分析：エンドユーザー別、用途別 - 業界予測（2023年～2030年）Global CRISPR Technology Market Size, Share, Growth Analysis, By End-User(Pharmaceutical and biotechnology companies and academic and research institutes), By Application(Drug discovery and development and agriculture) - Industry Forecast 2023-2030 |
||||||
|
|
|||||||
| CRISPR技術の世界市場 - 市場規模、シェア、成長分析：エンドユーザー別、用途別 - 業界予測（2023年～2030年） |
|
出版日: 2023年10月20日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界のCRISPR技術の市場規模は2021年に25億4,000万米ドル、2022年に29億4,000万米ドルとなりました。同市場は、予測期間中（2023年～2030年）に15.6%のCAGRで拡大し、2030年には108億4,000万米ドルに成長する見通しです。
世界のCRISPR技術市場は、バイオテクノロジー分野の中でも新興の有望分野です。CRISPRは、Clustered Regularly Interspaced Short Palindromic Repeatsの頭文字をとったもので、生物のDNAに正確な修正を加えることができる画期的な遺伝子編集技術です。この技術は、遺伝性疾患への対応、治療法開発の進歩、農業慣行の変革などの可能性を秘め、大きな注目を集めています。CRISPR技術市場は大幅な成長を遂げており、当面は拡大が続くと予想されています。この成長を促進する要因としては、個別化医療に対する需要の増加、遺伝子治療の進歩、遺伝性疾患の有病率の上昇などが挙げられます。さらに、創薬、市場開拓、診断ツールの作成におけるCRISPR技術の採用が、市場拡大にさらに拍車をかけています。さらに、産業バイオテクノロジー部門は、バイオエンジニアリングやバイオ製造の目的でCRISPR技術を活用しています。CRISPRを用いることで、研究者は新規酵素、バイオ燃料、特殊化学品を開発することができ、従来の製造プロセスに代わる持続可能な選択肢を提供することができます。結論として、世界市場は、さまざまな産業に革命を起こす可能性を秘めた、急速に発展する有望な分野です。ヘルスケア、農業、工業用バイオテクノロジーへの応用は、人々の健康を改善し、食糧生産を向上させ、持続可能な製造業を進展させる見込みがあります。研究開発が進むにつれて、倫理的および規制上の考慮事項に対処することは、将来におけるCRISPR技術の責任ある有益な使用を保証するために極めて重要です。
世界中の政府がCRISPR技術への融資と投資を大幅に増やしています。その結果、この分野は研究開発に有利な環境を提供し、画期的な発見を可能にし、市場を発展させています。
当レポートは、世界のCRISPR技術市場について調査し、市場の概要とともに、エンドユーザー別、用途別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。
目次
エグゼクティブサマリー
親市場分析
市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主要な市場の洞察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 動向分析
- スタートアップ分析
- 原材料分析
- イノベーションマトリックス
- パイプライン製品分析
- マクロ経済指標
- トップ投資分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制状況
- ポーター分析
世界のCRISPR技術市場、エンドユーザー別
- 市場概要
- 製薬会社、バイオテクノロジー企業、学術研究機関
世界のCRISPR技術市場、用途別
- 市場概要
- 創薬開発、農業
世界のCRISPR技術市場、地域別
- 市場概要
- 北米
- 欧州
- アジア太平洋
- ラテンアメリカ
- 中東・アフリカ
競合情勢
- 主要企業プロファイル
- Editas Medicine, Inc.
- CRISPR Therapeutics
- Intellia Therapeutics
- Caribou Biosciences, Inc.
- Cellectis
- Precision Biosciences
- Sangamo Therapeutics
- Lonza Group Ltd.
- Merck KGaA
- Horizon Discovery Group plc
- Thermo Fisher Scientific
- Integrated DNA Technologies, Inc.
- GenScript Biotech Corporation
- Synthego Corporation
- New England Biolabs
- OriGene Technologies, Inc.
- Agilent Technologies, Inc.
- Takara Bio Inc.
- Addgene
- Eurofins Scientific
Global CRISPR Technology Market size was valued at USD 2.54 billion in 2021 and is poised to grow from USD 2.94 billion in 2022 to USD 10.84 billion by 2030, growing at a CAGR of 15.6% during the forecast period (2023-2030).
The global CRISPR technology market is an emerging and promising sector within the field of biotechnology. CRISPR, an acronym for Clustered Regularly Interspaced Short Palindromic Repeats, is a groundbreaking gene-editing technology that allows precise modifications to be made to the DNA of living organisms. This technology has garnered significant attention due to its potential to address genetic disorders, drive advancements in therapy development, and revolutionize agricultural practices. The CRISPR technology market has witnessed substantial growth and is expected to continue expanding in the foreseeable future. Factors driving this growth include the increasing demand for personalized medicine, advancements in gene therapy, and the rising prevalence of genetic diseases. Additionally, the adoption of CRISPR technology in drug discovery, development, and the creation of diagnostic tools has further fueled market expansion. Furthermore, the industrial biotechnology sector is leveraging CRISPR technology for bioengineering and bio-manufacturing purposes. By employing CRISPR, researchers can develop novel enzymes, biofuels, and specialty chemicals, providing sustainable alternatives to traditional manufacturing processes. In conclusion, the global market is a rapidly evolving and promising sector with the potential to revolutionize various industries. Its applications in healthcare, agriculture, and industrial biotechnology offer the prospect of improving human health, enhancing food production, and advancing sustainable manufacturing. As research and development continue, addressing ethical and regulatory considerations is crucial to ensure responsible and beneficial use of CRISPR technology in the future.
Top-down and bottom-up approaches were used to estimate and validate the size of the global CRISPR Technology Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global CRISPR Technology Market Segmental Analysis
Global CRISPR Technology Market is segmented by end-user, application, and region. Based on end-user, the market can be segmented into pharmaceutical and biotechnology companies and academic and research institutes. Based on application, the market is segmented into drug discovery and development and agriculture. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global CRISPR Technology Market Dynamics
Drivers of the Global CRISPR Technology Market
Growing investments and funding from governments
- Governments from all around the world have significantly increased their financing and investment in CRISPR technology. As a result, the field now offers a favourable environment for research and development, enabling ground-breaking discoveries and advancing the market.
Restraints in the Global CRISPR Technology Market
Technical challenges
- The field of gene editing is severely constrained by technical difficulties related to CRISPR technology. Despite the enormous potential of CRISPR, numerous challenges prevent its widespread application. These difficulties result from the complexity of accurate genome editing, off-target consequences, and effective delivery. For CRISPR technology to reach its full potential and experience its transformative effects across a variety of industries, it is imperative that these technological obstacles be removed.
Market Trends of Global CRISPR Technology Key
One key market trend in the CRISPR technology market is the increasing adoption of CRISPR in drug discovery and development. Pharmaceutical and biotechnology companies are recognizing the potential of CRISPR technology to accelerate the drug discovery process, improve target identification and validation, and enhance preclinical and clinical studies. CRISPR-based screening platforms allow researchers to identify and validate potential drug targets more efficiently, leading to the development of more effective therapies. Additionally, CRISPR enables the creation of disease models and organoids for studying disease mechanisms and evaluating drug candidates. Overall, the key market trends in the CRISPR technology market include the adoption of CRISPR in drug discovery, its applications in agriculture and food production, the development of CRISPR-based diagnostics, and the increasing emphasis on ethical and regulatory considerations. These trends highlight the expanding potential and impact of CRISPR technology across various industries.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global CRISPR Technology Market by End-User
- Market Overview
- Pharmaceutical and biotechnology companies and academic and research institutes
- Global CRISPR Technology Market by Application
- Market Overview
- Drug discovery and development and agriculture
- Global CRISPR Technology Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Editas Medicine, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CRISPR Therapeutics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Intellia Therapeutics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Caribou Biosciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cellectis (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Precision Biosciences (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sangamo Therapeutics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lonza Group Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Horizon Discovery Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Integrated DNA Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GenScript Biotech Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Synthego Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- New England Biolabs (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- OriGene Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Takara Bio Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Addgene (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
